Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2011 May 13;28619:16940-52. doi: 10.1074/jbc.M110.184192.
Show Gene links
Show Anatomy links
Involvement of dominant-negative spliced variants of the intermediate conductance Ca2+-activated K+ channel, K(Ca)3.1, in immune function of lymphoid cells.
Ohya S
,
Niwa S
,
Yanagi A
,
Fukuyo Y
,
Yamamura H
,
Imaizumi Y
.
???displayArticle.abstract???
The intermediate conductance Ca(2+)-activated K(+) channel (IK(Ca) channel) encoded by K(Ca)3.1 is responsible for the control of proliferation and differentiation in various types of cells. We identified novel spliced variants of K(Ca)3.1 (human (h) K(Ca)3.1b) from the human thymus, which were lacking the N-terminal domains of the original hK(Ca)3.1a as a result of alternative splicing events. hK(Ca)3.1b was significantly expressed in human lymphoid tissues. Western blot analysis showed that hK(Ca)3.1a proteins were mainly expressed in the plasma membrane fraction, whereas hK(Ca)3.1b was in the cytoplasmic fraction. We also identified a similar N terminus lacking K(Ca)3.1 variants from mice and rat lymphoid tissues (mK(Ca)3.1b and rK(Ca)3.1b). In the HEK293 heterologous expression system, the cellular distribution of cyan fluorescent protein-tagged hK(Ca)3.1a and/or YFP-tagged hK(Ca)3.1b isoforms showed that hK(Ca)3.1b suppressed the localization of hK(Ca)3.1a to the plasma membrane. In the Xenopus oocyte translation system, co-expression of hK(Ca)3.1b with hK(Ca)3.1a suppressed IK(Ca) channel activity of hK(Ca)3.1a in a dominant-negative manner. In addition, this study indicated that up-regulation of mK(Ca)3.1b in mouse thymocytes differentiated CD4(+)CD8(+) phenotype thymocytes into CD4(-)CD8(-) ones and suppressed concanavalin-A-stimulated thymocyte growth by down-regulation of mIL-2 transcripts. Anti-proliferative effects and down-regulation of mIL-2 transcripts were also observed in mK(Ca)3.1b-overexpressing mouse thymocytes. These suggest that the N-terminal domain of K(Ca)3.1 is critical for channel trafficking to the plasma membrane and that the fine-tuning of IK(Ca) channel activity modulated through alternative splicing events may be related to the control in physiological and pathophysiological conditions in T-lymphocytes.
Begenisich,
Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4.
2004, Pubmed
Begenisich,
Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4.
2004,
Pubmed
Boussiotis,
p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes.
2000,
Pubmed
Brenner,
Tissue-specific expression of a Ca(2+)-activated K+ channel is controlled by multiple upstream regulatory elements.
1996,
Pubmed
Brown,
Amino-termini isoforms of the Slack K+ channel, regulated by alternative promoters, differentially modulate rhythmic firing and adaptation.
2008,
Pubmed
,
Xenbase
Cahalan,
The functional network of ion channels in T lymphocytes.
2009,
Pubmed
Chandy,
K+ channels as targets for specific immunomodulation.
2004,
Pubmed
Cheong,
Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell proliferation.
2005,
Pubmed
Decimo,
SK3 trafficking in hippocampal cells: the role of different molecular domains.
2006,
Pubmed
Di,
Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis.
2010,
Pubmed
Dohda,
Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines.
2007,
Pubmed
Elliott,
IKCa1 activity is required for cell shrinkage, phosphatidylserine translocation and death in T lymphocyte apoptosis.
2003,
Pubmed
Fanger,
Differential Ca2+ influx, KCa channel activity, and Ca2+ clearance distinguish Th1 and Th2 lymphocytes.
2000,
Pubmed
Fanger,
Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels.
2001,
Pubmed
Gao,
Role of S3 and S4 transmembrane domain charged amino acids in channel biogenesis and gating of KCa2.3 and KCa3.1.
2008,
Pubmed
Gao,
Recycling of the Ca2+-activated K+ channel, KCa2.3, is dependent upon RME-1, Rab35/EPI64C, and an N-terminal domain.
2010,
Pubmed
Ghanshani,
Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences.
2000,
Pubmed
Ghanshani,
Human calcium-activated potassium channel gene KCNN4 maps to chromosome 19q13.2 in the region deleted in diamond-blackfan anemia.
1998,
Pubmed
Ghatta,
Large-conductance, calcium-activated potassium channels: structural and functional implications.
2006,
Pubmed
Ghiani,
Voltage-activated K+ channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells.
1999,
Pubmed
Gillett,
Alternative splicing and transcriptome profiling of experimental autoimmune encephalomyelitis using genome-wide exon arrays.
2009,
Pubmed
Grgic,
Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels.
2009,
Pubmed
Hogan,
Molecular basis of calcium signaling in lymphocytes: STIM and ORAI.
2010,
Pubmed
Hopkins,
Both N- and C-terminal regions contribute to the assembly and functional expression of homo- and heteromultimeric voltage-gated K+ channels.
1994,
Pubmed
,
Xenbase
Hu,
Differential ICAM-1 isoform expression regulates the development and progression of experimental autoimmune encephalomyelitis.
2010,
Pubmed
Ishii,
A human intermediate conductance calcium-activated potassium channel.
1997,
Pubmed
,
Xenbase
Jensen,
The Ca2+-activated K+ channel of intermediate conductance: a molecular target for novel treatments?
2001,
Pubmed
Joiner,
Calmodulin regulates assembly and trafficking of SK4/IK1 Ca2+-activated K+ channels.
2001,
Pubmed
Joiner,
hSK4, a member of a novel subfamily of calcium-activated potassium channels.
1997,
Pubmed
Kolski-Andreaco,
SK3-1C, a dominant-negative suppressor of SKCa and IKCa channels.
2004,
Pubmed
Köhler,
Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.
2003,
Pubmed
Köhler,
Small-conductance, calcium-activated potassium channels from mammalian brain.
1996,
Pubmed
,
Xenbase
Levitan,
Surface expression of Kv1 voltage-gated K+ channels is governed by a C-terminal motif.
2000,
Pubmed
Logsdon,
A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes.
1997,
Pubmed
Lundmark,
Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.
2007,
Pubmed
Mahaut-Smith,
Ca(2+)-activated K+ channels in rat thymic lymphocytes: activation by concanavalin A.
1991,
Pubmed
Miller,
Nuclear localization and dominant-negative suppression by a mutant SKCa3 N-terminal channel fragment identified in a patient with schizophrenia.
2001,
Pubmed
Monaghan,
The SK3 subunit of small conductance Ca2+-activated K+ channels interacts with both SK1 and SK2 subunits in a heterologous expression system.
2004,
Pubmed
Mourich,
Splicing in the immune system: potential targets for therapeutic intervention by antisense-mediated alternative splicing.
2009,
Pubmed
Ohya,
Cardioprotective effects of estradiol include the activation of large-conductance Ca(2+)-activated K(+) channels in cardiac mitochondria.
2005,
Pubmed
Ohya,
Molecular cloning of a novel gene involved in serotonin receptor-mediated signal transduction in rat stomach.
1997,
Pubmed
,
Xenbase
Pauly,
Immunofluorescent patterns of spectrin in lymphocyte cell lines.
1986,
Pubmed
Pietrzykowski,
Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol.
2008,
Pubmed
Roncarati,
Assembly and trafficking of human small conductance Ca2+-activated K+ channel SK3 are governed by different molecular domains.
2005,
Pubmed
Snyders,
Structure and function of cardiac potassium channels.
1999,
Pubmed
Srivastava,
Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1.
2006,
Pubmed
Stocker,
Ca(2+)-activated K+ channels: molecular determinants and function of the SK family.
2004,
Pubmed
Strang,
A central role for the T1 domain in voltage-gated potassium channel formation and function.
2001,
Pubmed
Syme,
Trafficking of the Ca2+-activated K+ channel, hIK1, is dependent upon a C-terminal leucine zipper.
2003,
Pubmed
Tomita,
Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents: implications in schizophrenia.
2003,
Pubmed
Wonderlin,
Potassium channels, proliferation and G1 progression.
1996,
Pubmed
Wulff,
Potassium channels as therapeutic targets for autoimmune disorders.
2003,
Pubmed
Wulff,
Targeting effector memory T-cells with Kv1.3 blockers.
2007,
Pubmed
